These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 367555)
21. Clinical findings in patients with hypercalcaemia. A preliminary investigation based on biochemical screening. Heedman PA; Stenström G Acta Med Scand; 1973 Mar; 193(3):167-73. PubMed ID: 4693780 [No Abstract] [Full Text] [Related]
22. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822 [TBL] [Abstract][Full Text] [Related]
23. [Hypercalcemia of cancer and myeloma]. Lemaire V Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):633-42. PubMed ID: 6395303 [TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic syndromes. Hyper- and hypocalcemia: pathogenesis and treatments. Gordan GS Ann N Y Acad Sci; 1974; 230():181-6. PubMed ID: 4522866 [No Abstract] [Full Text] [Related]
25. [The pathogenesis of the humoral hypercalcemia syndrome in patients with solid tumors]. Naafs MA; Silberbusch J Ned Tijdschr Geneeskd; 1989 May; 133(21):1065-9. PubMed ID: 2662028 [No Abstract] [Full Text] [Related]
26. Bisphosphonates and primary hyperparathyroidism. Rodan GA J Bone Miner Res; 2002 Nov; 17 Suppl 2():N150-3. PubMed ID: 12412793 [TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449 [TBL] [Abstract][Full Text] [Related]
29. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer. Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770 [TBL] [Abstract][Full Text] [Related]
30. Intravenous etidronate in the management of malignant hypercalcemia. Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667 [TBL] [Abstract][Full Text] [Related]
31. A case of lung cancer with hypercalcemia which was incidentally complicated with primary hyperparathyroidism due to parathyroid adenoma. Matsumoto J; Kojima T; Shimizu T; Kitashiro S; Konishi K; Matsumura Y; Kawarada Y; Ikeda H; Yoshiki T Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):151-3. PubMed ID: 12472397 [TBL] [Abstract][Full Text] [Related]
32. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy. Kovacs CS; MacDonald SM; Chik CL; Bruera E J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127 [TBL] [Abstract][Full Text] [Related]
33. [Hypercalcemia and neoplasms: recent advances in pathogenesis]. Virgolini L; Gallizia C Recenti Prog Med; 1990 Oct; 81(10):635-41. PubMed ID: 2291007 [TBL] [Abstract][Full Text] [Related]
39. Adult T-cell leukemia complicated by hypercalcemia. Report of three autopsy cases with special reference to the etiologic factor of hypercalcemia. Haratake J; Ishii N; Horie A; Matsumoto M; Oda S; Satoh K Acta Pathol Jpn; 1985 Mar; 35(2):437-48. PubMed ID: 3875211 [TBL] [Abstract][Full Text] [Related]